Get the Stockscreener App
3.66
2.40%
-0.09
After Hours:
3.70
0.04
+1.09%
Cellectis Adr Stock (CLLS) Forecast
The Cellectis Adr (CLLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $16.83, representing a +359.79% increase from the current price of $3.66. The highest analyst price target is $23.13, and the lowest is $10.53.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLLS Price Target
Average 11.82
(+223.06% Upside)
Is Cellectis Adr (CLLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.57 | Neutral |
| STOCH(9,6) | 20.17 | Neutral |
| STOCHRSI(14) | 4.3049 | Buy |
| MACD(12,26) | -0.072 | Sell |
| ADX(14) | 12.47 | Neutral |
| William %R | -88.73 | Buy |
| CCI(14) | -75.35 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.879
Sell
|
3.8137
Sell
|
| MA20 |
3.8135
Sell
|
3.8628
Sell
|
| MA50 |
4.1233
Sell
|
3.992
Sell
|
| MA100 |
4.1389
Sell
|
3.8888
Sell
|
| MA200 |
3.2387
Buy
|
3.4001
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, CLLS could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on CLLS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.57 indicates that CLLS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.17 indicates that CLLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.3049 indicates that CLLS is oversold. This suggests that CLLS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.47 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -75.35 indicates that CLLS is still oversold but not to an extreme extent.
Long-term CLLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cellectis Adr financial reports and earnings history, Cellectis Adr (CLLS) stock could reach $16.30 by 2030, $13.95 by 2040 and $37.84 by 2050. See the projected annual prices until 2050 of the Cellectis Adr stock below:
- Cellectis Adr (CLLS) is expected to reach an average price of $4.1757 in 2035, with a high prediction of $6.4207 and a low estimate of $4.3357. This indicates an $14.09% rise from the last recorded price of $3.66.
- Cellectis Adr (CLLS) stock is projected to chart a bullish course in 2040, with an average price target of $13.66, representing an $273.15% surge from its current level. The forecast ranges from a conservative $13.66 to a sky-high $13.95.
- Our analysts predict Cellectis Adr (CLLS) to jump 571.83% by 2045, soaring from $24.60 to an average price of $24.59, potentially reaching $24.76. While $24.60 is the low estimate, the potential upside is significant.
- Cellectis Adr (CLLS) stock is expected to climb by 2050, reaching an average of $37.72, a $930.51% jump from its current level. However, a wide range of estimates exists, with high and low targets of $37.84 and $37.73, respectively, highlighting the market's uncertainty.
Cellectis Adr Stock (CLLS) Year by Year Forecast
Cellectis Adr Stock (CLLS) Price Forecast for 2026
The predicted value for Cellectis Adr (CLLS) in 2026 is set at an average of $12.49. Estimates vary from a peak of $23.13 to a trough of $1.8403, indicating an +241.13% surge from the present price of $3.66.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $13.70 | $10.53 | $23.13 | +274.39% |
| May, 2026 | $10.24 | $5.7091 | $13.12 | +179.65% |
| June, 2026 | $8.9178 | $6.6635 | $11.05 | +143.66% |
| July, 2026 | $4.7285 | $3.4885 | $9.5622 | +29.19% |
| August, 2026 | $4.611 | $3.5628 | $6.1466 | +25.98% |
| September, 2026 | $5.4516 | $3.2216 | $6.0253 | +48.95% |
| October, 2026 | $4.1241 | $2.366 | $5.5597 | +12.68% |
| November, 2026 | $4.4366 | $1.8403 | $5.0122 | +21.22% |
| December, 2026 | $2.8972 | $2.6672 | $5.6047 | -20.84% |
Cellectis Adr Stock (CLLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cellectis Adr (CLLS) is $2.7056, with a high forecast of $4.8934 and a low forecast of $0.5178. This indicates an -26.08% decrease from the last price of $3.66.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.3197 | $0.6084 | $3.2834 | -63.94% |
| February, 2027 | $0.4078 | $0.5178 | $3.6659 | -88.86% |
| March, 2027 | $0.00718 | $1.0716 | $0.4497 | -99.80% |
| April, 2027 | $1.5947 | $0.8591 | $0.3409 | -56.43% |
| May, 2027 | $2.9022 | $2.2466 | $2.3003 | -20.71% |
| June, 2027 | $4.9216 | $3.4041 | $3.9416 | +34.47% |
| July, 2027 | $3.7191 | $4.0591 | $3.6334 | +1.61% |
| August, 2027 | $4.2866 | $3.7009 | $3.9016 | +17.12% |
| September, 2027 | $3.8459 | $4.4059 | $4.6522 | +5.08% |
| October, 2027 | $4.9434 | $4.1578 | $4.8934 | +35.07% |
| November, 2027 | $4.6409 | $4.8072 | $4.6191 | +26.80% |
| December, 2027 | $3.3903 | $3.9003 | $4.6128 | -7.37% |
Cellectis Adr Stock (CLLS) Price Forecast for 2028
In 2028, Cellectis Adr (CLLS) is projected to reach an average price of $3.5797, with a high projection of $4.3153 and a low estimate of $2.8441. This indicates an -2.19% fall from the last price of $3.66.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.6178 | $3.8122 | $3.6641 | -1.15% |
| February, 2028 | $4.5253 | $3.8597 | $4.3153 | +23.64% |
| March, 2028 | $4.0897 | $4.1047 | $4.1891 | +11.74% |
| April, 2028 | $4.0322 | $4.1966 | $3.9803 | +10.17% |
| May, 2028 | $4.1516 | $4.1078 | $4.046 | +13.43% |
| June, 2028 | $2.8891 | $2.9572 | $3.9835 | -21.06% |
| July, 2028 | $3.4266 | $2.881 | $3.1166 | -6.38% |
| August, 2028 | $3.526 | $3.4341 | $3.3122 | -3.66% |
| September, 2028 | $3.3535 | $3.4335 | $3.3978 | -8.38% |
| October, 2028 | $3.231 | $3.2991 | $3.2391 | -11.72% |
| November, 2028 | $2.9003 | $3.0002 | $3.2149 | -20.76% |
| December, 2028 | $2.7303 | $2.8441 | $2.746 | -25.40% |
Cellectis Adr Stock (CLLS) Price Forecast for 2029
The 2029 price forecast for Cellectis Adr Stock (CLLS) is $6.1491 on average, with a high prediction of $12.29 and a low estimate of $0.0103. This represents an +68.01% increase from the previous price of $3.66.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.3172 | $2.417 | $2.5997 | -36.69% |
| February, 2029 | $2.3647 | $2.4347 | $2.4114 | -35.39% |
| March, 2029 | $2.3522 | $2.1885 | $2.1722 | -35.73% |
| April, 2029 | $2.4997 | $2.396 | $2.4097 | -31.70% |
| May, 2029 | $1.1291 | $1.3291 | $2.6853 | -69.15% |
| June, 2029 | $0.4066 | $0.6166 | $0.661 | -88.89% |
| July, 2029 | $0.1741 | $0.1022 | $0.4713 | -95.24% |
| August, 2029 | $0.0235 | $0.1835 | $0.2355 | -99.36% |
| September, 2029 | $0.00902 | $0.0672 | $0.2209 | -99.75% |
| October, 2029 | $0.0804 | $0.1904 | $0.1034 | -97.80% |
| November, 2029 | $0.1621 | $0.0741 | $0.4659 | -95.57% |
| December, 2029 | $13.81 | $0.0103 | $12.29 | +277.27% |
Cellectis Adr Stock (CLLS) Price Forecast for 2030
Cellectis Adr Stock (CLLS) is expected to reach an average price of $15.51 in 2030, with a high forecast of $20.01 and a low forecast of $11.01. This signifies an +323.82% surge from the last price of $3.66.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.32 | $14.53 | $16.30 | +373.14% |
| February, 2030 | $15.73 | $16.07 | $16.90 | +329.83% |
| March, 2030 | $17.66 | $16.62 | $16.42 | +382.43% |
| April, 2030 | $18.90 | $19.03 | $18.63 | +416.44% |
| May, 2030 | $20.10 | $19.10 | $20.01 | +449.06% |
| June, 2030 | $19.29 | $20.28 | $20.00 | +426.93% |
| July, 2030 | $16.33 | $16.79 | $18.11 | +346.29% |
| August, 2030 | $11.19 | $13.79 | $15.33 | +205.72% |
| September, 2030 | $10.65 | $11.70 | $10.83 | +191.10% |
| October, 2030 | $11.01 | $11.01 | $11.78 | +200.90% |
| November, 2030 | $18.31 | $11.46 | $14.95 | +400.22% |
| December, 2030 | $19.43 | $19.12 | $18.70 | +430.96% |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):